APA

Weigold F., Günther J., Pfeiffenberger M., Cabral-Marques O., Siegert E., Dragun D., Philippe A., Regensburger A., Recke A., Yu X., Petersen F., Catar R., Biesen R., Hiepe F., Burmester G. R., Heidecke H. & Riemekasten G. (20190415). Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. : Arthritis research & therapy.

Chicago

Weigold Florian, Günther Jeannine, Pfeiffenberger Moritz, Cabral-Marques Otavio, Siegert Elise, Dragun Duska, Philippe Aurélie, Regensburger Ann-Katrin, Recke Andreas, Yu Xinhua, Petersen Frank, Catar Rusan, Biesen Robert, Hiepe Falk, Burmester Gerd R, Heidecke Harald and Riemekasten Gabriela. 20190415. Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. : Arthritis research & therapy.

Harvard

Weigold F., Günther J., Pfeiffenberger M., Cabral-Marques O., Siegert E., Dragun D., Philippe A., Regensburger A., Recke A., Yu X., Petersen F., Catar R., Biesen R., Hiepe F., Burmester G. R., Heidecke H. and Riemekasten G. (20190415). Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. : Arthritis research & therapy.

MLA

Weigold Florian, Günther Jeannine, Pfeiffenberger Moritz, Cabral-Marques Otavio, Siegert Elise, Dragun Duska, Philippe Aurélie, Regensburger Ann-Katrin, Recke Andreas, Yu Xinhua, Petersen Frank, Catar Rusan, Biesen Robert, Hiepe Falk, Burmester Gerd R, Heidecke Harald and Riemekasten Gabriela. Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. : Arthritis research & therapy. 20190415.